Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA
View Patent ↗The nuclear reprogramming of somatic cells with mRNA encoding reprogramming factors is shown to be greatly accelerated by activation of innate immune responses in the somatic cell. Methods of activating innate immunity include activation of PKR, of toll-like receptors, e.g. TLR3, etc. In some embodiments the mRNA provides the activator of innate immunity.
1. A method of nuclear reprogramming of a mammalian somatic cell, the method comprising:
contacting a population of mammalian somatic cells with a population of modified mRNAs (mmRNAs) encoding a cocktail of reprogramming transcriptional factors wherein at least 5% of the mmRNA population comprises 5′ triphosphate and wherein the mmRNA is modified by inclusion of one or both of 5-methylcytidine and pseudouridine; for a period of time sufficient to reprogram said mammalian somatic cells to a pluripotent cell, wherein reprogramming is increased in efficiency compared to reprogramming with mmRNA lacking 5′ triphosphate.
2. The method of claim 1 , wherein up to about 25% of the mmRNA population comprises 5′ triphosphate.
3. The method of claim 1 , wherein the balance of mmRNAs in the population comprises a 5′ cap structure.
4. The method of claim 1 , wherein the mammalian somatic cells are human cells.
5. A method of nuclear reprogramming of a mammalian somatic cell, the method comprising:
contacting a population of mammalian somatic cells with a population of modified mRNAs (mmRNAs) encoding a cocktail of lineage specific transcriptional factors wherein at least 5% of the mmRNA population comprises 5′ triphosphate and wherein the mmRNA is modified by inclusion of one or both of 5-methylcytidine and pseudouridine; for a period of time sufficient to transdifferentiate said mammalian somatic cells to a desired cell type of interest, wherein the cells are transdifferentiated to a different somatic cell type, wherein transdifferentiation is increased in efficiency compared to transdifferentiation with mmRNA lacking 5′ triphosphate.
6. The method of claim 5 , wherein the mammalian somatic cells are reprogrammed from a senescent to a juvenile form, by contacting the cells with hTERT or p-hTERT mmRNAs to extend telomeres.
7. The method of claim 5 , wherein up to about 25% of the mmRNA population comprises 5′ triphosphate.
8. The method of claim 5 , wherein the balance of mmRNAs in the population comprises a 5′ cap structure.
9. The method of claim 5 , wherein the mammalian somatic cells are human cells.